Ignite Creation Date:
2025-12-25 @ 1:18 AM
Ignite Modification Date:
2026-05-02 @ 2:20 PM
Study NCT ID:
NCT06303193
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-12-24
First Post:
2024-03-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
Sponsor:
Organization: